has shown that high expression of MYEOV is significantly correlated with a low survival rate in patients with Pancreatic Ductal Adenocarcinoma (PDAC), with high expression of MYEOV promoting glycolysis in PDAC tumor cells. This evidence concerns the gene MYEOV and pancreatic ductal adenocarcinoma.